Literature DB >> 10655727

[Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].

I Yashima1, T Hirayama, H Shiiki, M Kanauchi, K Dohi.   

Abstract

An early manifestation of diabetic nephropathy, increased excretion of albumin, is now generally believed to be sufficiently specific, particularly in subjects with diabetes mellitus, to predict the subsequent development of clinically overt diabetic nephropathy. However, certain other proteins besides albumin may also be excreted in abnormal amounts during this early phase of diabetic nephropathy. We evaluated the diagnostic utility of urinary immunoglobulin G (IgG) in patients with diabetic nephropathy by comparing the findings with the clinical stage and renal biopsy specimen. Using 24-hour urine samples, IgG was measured by an enzyme-linked immunosorbent assay. In addition, urine samples were assayed for albumin, transferrin, beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase. Serum IgG concentration and HbA1c were also evaluated. A total of 197 patients with non-insulin-dependent diabetes mellitus were enrolled in this study. Subjects were grouped according to the rate of urinary albumin excretion (clinical stage). Fifty of these cases were also divided into four groups according to the severity of diffuse glomerular lesions using Gellman's criteria. The urinary excretion of IgG was significantly increased in diabetic patients as compared with the healthy controls. Among diabetic patients, IgG level showed a significant increase with respect to the clinical stage of nephropathy and the progress of glomerular diffuse lesions. In the stage of normoalbuminuria, the urinary excretion of IgG showed a significant increase in parallel with the progress of glomerular diffuse lesions, whereas there was no relationship between the urinary excretion of albumin and the progress of glomerular diffuse lesions. While the excretion of IgG correlated with that of albumin and transferrin, there was no correlation between the excretion of IgG and the other laboratory indices evaluated. These findings indicate that measurement of urinary IgG may be more useful than albuminuria in detecting the early stage of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10655727

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  5 in total

Review 1.  Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.

Authors:  Zubair Ilyas; Joumana T Chaiban; Armand Krikorian
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 2.  Novel biomarkers for prognosticating diabetic kidney disease progression.

Authors:  Shilna Muttickal Swaminathan; Indu Ramachandra Rao; Srinivas Vinayak Shenoy; Attur Ravindra Prabhu; Pooja Basthi Mohan; Dharshan Rangaswamy; Mohan V Bhojaraja; Shivashankara Kaniyoor Nagri; Shankar Prasad Nagaraju
Journal:  Int Urol Nephrol       Date:  2022-10-22       Impact factor: 2.266

3.  Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.

Authors:  Kinnari Mistry; Kiran Kalia
Journal:  Indian J Clin Biochem       Date:  2009-07-09

4.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

Review 5.  Emerging Biomarkers for Early Detection of Chronic Kidney Disease.

Authors:  Maja Mizdrak; Marko Kumrić; Tina Tičinović Kurir; Joško Božić
Journal:  J Pers Med       Date:  2022-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.